These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

706 related articles for article (PubMed ID: 34532856)

  • 21. Position Emission Tomography/Single-Photon Emission Tomography Neuroimaging for Detection of Premotor Parkinson's Disease.
    Zou J; Weng RH; Chen ZY; Wei XB; Wang R; Chen D; Xia Y; Wang Q
    CNS Neurosci Ther; 2016 Mar; 22(3):167-77. PubMed ID: 26776081
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroimaging in Parkinson's disease.
    Stoessl AJ
    Neurotherapeutics; 2011 Jan; 8(1):72-81. PubMed ID: 21274687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circuit imaging biomarkers in preclinical and prodromal Parkinson's disease.
    Meles SK; Oertel WH; Leenders KL
    Mol Med; 2021 Sep; 27(1):111. PubMed ID: 34530732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Positron emission computed tomography/single photon emission computed tomography in Parkinson disease.
    Yao NT; Zheng Q; Xu ZQ; Yin JH; Lu LG; Zuo Q; Yang S; Zhang CL; Jiao L
    Chin Med J (Engl); 2020 Jun; 133(12):1448-1455. PubMed ID: 32404694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Imaging the Nonmotor Symptoms in Parkinson's Disease.
    Yousaf T; Wilson H; Politis M
    Int Rev Neurobiol; 2017; 133():179-257. PubMed ID: 28802921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Precise Evaluation of Striatal Oxidative Stress Corrected for Severity of Dopaminergic Neuronal Degeneration in Patients with Parkinson's Disease: A Study with 62Cu-ATSM PET and 123I-FP-CIT SPECT.
    Neishi H; Ikawa M; Okazawa H; Tsujikawa T; Arishima H; Kikuta KI; Yoneda M
    Eur Neurol; 2017; 78(3-4):161-168. PubMed ID: 28848099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson's disease.
    Doppler K; Jentschke HM; Schulmeyer L; Vadasz D; Janzen A; Luster M; Höffken H; Mayer G; Brumberg J; Booij J; Musacchio T; Klebe S; Sittig-Wiegand E; Volkmann J; Sommer C; Oertel WH
    Acta Neuropathol; 2017 Apr; 133(4):535-545. PubMed ID: 28180961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced α-synuclein levels in cerebrospinal fluid in Parkinson's disease are unrelated to clinical and imaging measures of disease severity.
    van Dijk KD; Bidinosti M; Weiss A; Raijmakers P; Berendse HW; van de Berg WD
    Eur J Neurol; 2014 Mar; 21(3):388-94. PubMed ID: 23631635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroimaging advances in Parkinson's disease.
    Rispoli V; Schreglmann SR; Bhatia KP
    Curr Opin Neurol; 2018 Aug; 31(4):415-424. PubMed ID: 29878908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroimaging in Parkinson's Disease: necessity or exaggeration?
    Śmiłowska K; Burzyńska-Makuch M; Brockhuis B; Piekarski R; Friedman A; Popek A; Sławek J
    Neurol Neurochir Pol; 2021; 55(6):536-548. PubMed ID: 34637136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroimaging in Parkinson's disease: from pathology to diagnosis.
    Stoessl AJ
    Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S55-9. PubMed ID: 22166455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Not Available].
    Prange S; Hermier M; Danaila T; Laurencin C; Thobois S
    Presse Med; 2017 Mar; 46(2 Pt 1):202-209. PubMed ID: 28040345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular Imaging of the Dopaminergic System in Idiopathic Parkinson's Disease.
    de Natale ER; Niccolini F; Wilson H; Politis M
    Int Rev Neurobiol; 2018; 141():131-172. PubMed ID: 30314595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SPECT molecular imaging in Parkinson's disease.
    Wang L; Zhang Q; Li H; Zhang H
    J Biomed Biotechnol; 2012; 2012():412486. PubMed ID: 22529704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What a neurologist should know about PET and SPECT functional imaging for parkinsonism: A practical perspective.
    Thobois S; Prange S; Scheiber C; Broussolle E
    Parkinsonism Relat Disord; 2019 Feb; 59():93-100. PubMed ID: 30181086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The challenging quest of neuroimaging: From clinical to molecular-based subtyping of Parkinson disease and atypical parkinsonisms.
    Sasikumar S; Strafella AP
    Handb Clin Neurol; 2023; 192():231-258. PubMed ID: 36796945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Basal ganglia dysfunction in idiopathic REM sleep behaviour disorder parallels that in early Parkinson's disease.
    Rolinski M; Griffanti L; Piccini P; Roussakis AA; Szewczyk-Krolikowski K; Menke RA; Quinnell T; Zaiwalla Z; Klein JC; Mackay CE; Hu MT
    Brain; 2016 Aug; 139(Pt 8):2224-34. PubMed ID: 27297241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroimaging in Parkinson's disease.
    Brooks DJ
    NeuroRx; 2004 Apr; 1(2):243-54. PubMed ID: 15717025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PET imaging in animal models of Parkinson's disease.
    Ni R
    Behav Brain Res; 2023 Feb; 438():114174. PubMed ID: 36283568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroimaging of depression in Parkinson's disease: a review.
    Chagas MH; Linares IM; Garcia GJ; Hallak JE; Tumas V; Crippa JA
    Int Psychogeriatr; 2013 Dec; 25(12):1953-61. PubMed ID: 23992107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.